Global TCR-T Cellular Immunotherapy Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
TCR-T (T Cell Receptor-Engineered T cell) immunotherapy is a type of adoptive cellular immunotherapy, which harnesses the power of a patient's own immune system to fight cancer. It is an advanced and personalized approach in cancer treatment that involves genetic modification of a patient's T cells, a type of white blood cell that plays a crucial role in immune response.
The global TCR-T Cellular Immunotherapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “TCR-T Cellular Immunotherapy Industry Forecast” looks at past sales and reviews total world TCR-T Cellular Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected TCR-T Cellular Immunotherapy sales for 2023 through 2029. With TCR-T Cellular Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TCR-T Cellular Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global TCR-T Cellular Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on TCR-T Cellular Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TCR-T Cellular Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TCR-T Cellular Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TCR-T Cellular Immunotherapy.
United States market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TCR-T Cellular Immunotherapy players cover BioNTech, Adaptimmune, Immunocore, Medigene AG, bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TCR-T Cellular Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
TCR-T (T Cell Receptor-Engineered T cell) immunotherapy is a type of adoptive cellular immunotherapy, which harnesses the power of a patient's own immune system to fight cancer. It is an advanced and personalized approach in cancer treatment that involves genetic modification of a patient's T cells, a type of white blood cell that plays a crucial role in immune response.
The global TCR-T Cellular Immunotherapy market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “TCR-T Cellular Immunotherapy Industry Forecast” looks at past sales and reviews total world TCR-T Cellular Immunotherapy sales in 2022, providing a comprehensive analysis by region and market sector of projected TCR-T Cellular Immunotherapy sales for 2023 through 2029. With TCR-T Cellular Immunotherapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world TCR-T Cellular Immunotherapy industry.
This Insight Report provides a comprehensive analysis of the global TCR-T Cellular Immunotherapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on TCR-T Cellular Immunotherapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global TCR-T Cellular Immunotherapy market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for TCR-T Cellular Immunotherapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global TCR-T Cellular Immunotherapy.
United States market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for TCR-T Cellular Immunotherapy is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key TCR-T Cellular Immunotherapy players cover BioNTech, Adaptimmune, Immunocore, Medigene AG, bluebird bio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of TCR-T Cellular Immunotherapy market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Autologous
- Allogeneic
- Cervical Cancer
- Colorectal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Lung Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Autologous
- Allogeneic
- Cervical Cancer
- Colorectal Cancer
- Esophageal Cancer
- Pancreatic Cancer
- Lung Cancer
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BioNTech
- Adaptimmune
- Immunocore
- Medigene AG
- bluebird bio
- TCR2 Therapeutics
- Immatics
- TScan Therapeutics
- 3T Biosciences
- Adaptive Biotechnologies
- Kite Pharma
- RootPath
- Eureka Therapeutics
- Lion TCR
- Guangzhou Xiangxue Pharmaceutical
- Fosun Kite Biotechnology
- Shanghai JW Therapeutics
- Shanghai Heng Rui Yuan Zheng Biotechnology
- Shenzhen Innovation Immunotechnology
- Suzhou Neowise Biotechnology
- Shenzhen BinDeBio Technology
- Beijing CorreGene Biotechnology
- TCRCure Biopharma Technology
- BriSTAR Immunotech
- Shanghai iCell Biotechnology
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TCR-T Cellular Immunotherapy Market Size 2019-2030
2.1.2 TCR-T Cellular Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for TCR-T Cellular Immunotherapy by Country/Region, 2019, 2023 & 2030
2.2 TCR-T Cellular Immunotherapy Segment by Type
2.2.1 Autologous
2.2.2 Allogeneic
2.3 TCR-T Cellular Immunotherapy Market Size by Type
2.3.1 TCR-T Cellular Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 TCR-T Cellular Immunotherapy Segment by Application
2.4.1 Cervical Cancer
2.4.2 Colorectal Cancer
2.4.3 Esophageal Cancer
2.4.4 Pancreatic Cancer
2.4.5 Lung Cancer
2.5 TCR-T Cellular Immunotherapy Market Size by Application
2.5.1 TCR-T Cellular Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
3 TCR-T CELLULAR IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 TCR-T Cellular Immunotherapy Market Size Market Share by Player
3.1.1 Global TCR-T Cellular Immunotherapy Revenue by Player (2019-2024)
3.1.2 Global TCR-T Cellular Immunotherapy Revenue Market Share by Player (2019-2024)
3.2 Global TCR-T Cellular Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TCR-T CELLULAR IMMUNOTHERAPY BY REGION
4.1 TCR-T Cellular Immunotherapy Market Size by Region (2019-2024)
4.2 Global TCR-T Cellular Immunotherapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.4 APAC TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.5 Europe TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.6 Middle East & Africa TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas TCR-T Cellular Immunotherapy Market Size by Country (2019-2024)
5.2 Americas TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
5.3 Americas TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TCR-T Cellular Immunotherapy Market Size by Region (2019-2024)
6.2 APAC TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
6.3 APAC TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe TCR-T Cellular Immunotherapy Market Size by Country (2019-2024)
7.2 Europe TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
7.3 Europe TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TCR-T Cellular Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TCR-T CELLULAR IMMUNOTHERAPY MARKET FORECAST
10.1 Global TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.1.1 Global TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.1.2 Americas TCR-T Cellular Immunotherapy Forecast
10.1.3 APAC TCR-T Cellular Immunotherapy Forecast
10.1.4 Europe TCR-T Cellular Immunotherapy Forecast
10.1.5 Middle East & Africa TCR-T Cellular Immunotherapy Forecast
10.2 Americas TCR-T Cellular Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Market TCR-T Cellular Immunotherapy Forecast
10.2.2 Canada Market TCR-T Cellular Immunotherapy Forecast
10.2.3 Mexico Market TCR-T Cellular Immunotherapy Forecast
10.2.4 Brazil Market TCR-T Cellular Immunotherapy Forecast
10.3 APAC TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.3.1 China TCR-T Cellular Immunotherapy Market Forecast
10.3.2 Japan Market TCR-T Cellular Immunotherapy Forecast
10.3.3 Korea Market TCR-T Cellular Immunotherapy Forecast
10.3.4 Southeast Asia Market TCR-T Cellular Immunotherapy Forecast
10.3.5 India Market TCR-T Cellular Immunotherapy Forecast
10.3.6 Australia Market TCR-T Cellular Immunotherapy Forecast
10.4 Europe TCR-T Cellular Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Market TCR-T Cellular Immunotherapy Forecast
10.4.2 France Market TCR-T Cellular Immunotherapy Forecast
10.4.3 UK Market TCR-T Cellular Immunotherapy Forecast
10.4.4 Italy Market TCR-T Cellular Immunotherapy Forecast
10.4.5 Russia Market TCR-T Cellular Immunotherapy Forecast
10.5 Middle East & Africa TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Market TCR-T Cellular Immunotherapy Forecast
10.5.2 South Africa Market TCR-T Cellular Immunotherapy Forecast
10.5.3 Israel Market TCR-T Cellular Immunotherapy Forecast
10.5.4 Turkey Market TCR-T Cellular Immunotherapy Forecast
10.6 Global TCR-T Cellular Immunotherapy Forecast by Type (2025-2030)
10.7 Global TCR-T Cellular Immunotherapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market TCR-T Cellular Immunotherapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech
11.1.1 BioNTech Company Information
11.1.2 BioNTech TCR-T Cellular Immunotherapy Product Offered
11.1.3 BioNTech TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BioNTech Main Business Overview
11.1.5 BioNTech Latest Developments
11.2 Adaptimmune
11.2.1 Adaptimmune Company Information
11.2.2 Adaptimmune TCR-T Cellular Immunotherapy Product Offered
11.2.3 Adaptimmune TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Adaptimmune Main Business Overview
11.2.5 Adaptimmune Latest Developments
11.3 Immunocore
11.3.1 Immunocore Company Information
11.3.2 Immunocore TCR-T Cellular Immunotherapy Product Offered
11.3.3 Immunocore TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Immunocore Main Business Overview
11.3.5 Immunocore Latest Developments
11.4 Medigene AG
11.4.1 Medigene AG Company Information
11.4.2 Medigene AG TCR-T Cellular Immunotherapy Product Offered
11.4.3 Medigene AG TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Medigene AG Main Business Overview
11.4.5 Medigene AG Latest Developments
11.5 bluebird bio
11.5.1 bluebird bio Company Information
11.5.2 bluebird bio TCR-T Cellular Immunotherapy Product Offered
11.5.3 bluebird bio TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 bluebird bio Main Business Overview
11.5.5 bluebird bio Latest Developments
11.6 TCR2 Therapeutics
11.6.1 TCR2 Therapeutics Company Information
11.6.2 TCR2 Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.6.3 TCR2 Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TCR2 Therapeutics Main Business Overview
11.6.5 TCR2 Therapeutics Latest Developments
11.7 Immatics
11.7.1 Immatics Company Information
11.7.2 Immatics TCR-T Cellular Immunotherapy Product Offered
11.7.3 Immatics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Immatics Main Business Overview
11.7.5 Immatics Latest Developments
11.8 TScan Therapeutics
11.8.1 TScan Therapeutics Company Information
11.8.2 TScan Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.8.3 TScan Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 TScan Therapeutics Main Business Overview
11.8.5 TScan Therapeutics Latest Developments
11.9 3T Biosciences
11.9.1 3T Biosciences Company Information
11.9.2 3T Biosciences TCR-T Cellular Immunotherapy Product Offered
11.9.3 3T Biosciences TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 3T Biosciences Main Business Overview
11.9.5 3T Biosciences Latest Developments
11.10 Adaptive Biotechnologies
11.10.1 Adaptive Biotechnologies Company Information
11.10.2 Adaptive Biotechnologies TCR-T Cellular Immunotherapy Product Offered
11.10.3 Adaptive Biotechnologies TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Adaptive Biotechnologies Main Business Overview
11.10.5 Adaptive Biotechnologies Latest Developments
11.11 Kite Pharma
11.11.1 Kite Pharma Company Information
11.11.2 Kite Pharma TCR-T Cellular Immunotherapy Product Offered
11.11.3 Kite Pharma TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Kite Pharma Main Business Overview
11.11.5 Kite Pharma Latest Developments
11.12 RootPath
11.12.1 RootPath Company Information
11.12.2 RootPath TCR-T Cellular Immunotherapy Product Offered
11.12.3 RootPath TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RootPath Main Business Overview
11.12.5 RootPath Latest Developments
11.13 Eureka Therapeutics
11.13.1 Eureka Therapeutics Company Information
11.13.2 Eureka Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.13.3 Eureka Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eureka Therapeutics Main Business Overview
11.13.5 Eureka Therapeutics Latest Developments
11.14 Lion TCR
11.14.1 Lion TCR Company Information
11.14.2 Lion TCR TCR-T Cellular Immunotherapy Product Offered
11.14.3 Lion TCR TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lion TCR Main Business Overview
11.14.5 Lion TCR Latest Developments
11.15 Guangzhou Xiangxue Pharmaceutical
11.15.1 Guangzhou Xiangxue Pharmaceutical Company Information
11.15.2 Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Product Offered
11.15.3 Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Guangzhou Xiangxue Pharmaceutical Main Business Overview
11.15.5 Guangzhou Xiangxue Pharmaceutical Latest Developments
11.16 Fosun Kite Biotechnology
11.16.1 Fosun Kite Biotechnology Company Information
11.16.2 Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.16.3 Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Fosun Kite Biotechnology Main Business Overview
11.16.5 Fosun Kite Biotechnology Latest Developments
11.17 Shanghai JW Therapeutics
11.17.1 Shanghai JW Therapeutics Company Information
11.17.2 Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.17.3 Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Shanghai JW Therapeutics Main Business Overview
11.17.5 Shanghai JW Therapeutics Latest Developments
11.18 Shanghai Heng Rui Yuan Zheng Biotechnology
11.18.1 Shanghai Heng Rui Yuan Zheng Biotechnology Company Information
11.18.2 Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.18.3 Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Shanghai Heng Rui Yuan Zheng Biotechnology Main Business Overview
11.18.5 Shanghai Heng Rui Yuan Zheng Biotechnology Latest Developments
11.19 Shenzhen Innovation Immunotechnology
11.19.1 Shenzhen Innovation Immunotechnology Company Information
11.19.2 Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Product Offered
11.19.3 Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Shenzhen Innovation Immunotechnology Main Business Overview
11.19.5 Shenzhen Innovation Immunotechnology Latest Developments
11.20 Suzhou Neowise Biotechnology
11.20.1 Suzhou Neowise Biotechnology Company Information
11.20.2 Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.20.3 Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Suzhou Neowise Biotechnology Main Business Overview
11.20.5 Suzhou Neowise Biotechnology Latest Developments
11.21 Shenzhen BinDeBio Technology
11.21.1 Shenzhen BinDeBio Technology Company Information
11.21.2 Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Product Offered
11.21.3 Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Shenzhen BinDeBio Technology Main Business Overview
11.21.5 Shenzhen BinDeBio Technology Latest Developments
11.22 Beijing CorreGene Biotechnology
11.22.1 Beijing CorreGene Biotechnology Company Information
11.22.2 Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.22.3 Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Beijing CorreGene Biotechnology Main Business Overview
11.22.5 Beijing CorreGene Biotechnology Latest Developments
11.23 TCRCure Biopharma Technology
11.23.1 TCRCure Biopharma Technology Company Information
11.23.2 TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Product Offered
11.23.3 TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 TCRCure Biopharma Technology Main Business Overview
11.23.5 TCRCure Biopharma Technology Latest Developments
11.24 BriSTAR Immunotech
11.24.1 BriSTAR Immunotech Company Information
11.24.2 BriSTAR Immunotech TCR-T Cellular Immunotherapy Product Offered
11.24.3 BriSTAR Immunotech TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 BriSTAR Immunotech Main Business Overview
11.24.5 BriSTAR Immunotech Latest Developments
11.25 Shanghai iCell Biotechnology
11.25.1 Shanghai iCell Biotechnology Company Information
11.25.2 Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.25.3 Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Shanghai iCell Biotechnology Main Business Overview
11.25.5 Shanghai iCell Biotechnology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global TCR-T Cellular Immunotherapy Market Size 2019-2030
2.1.2 TCR-T Cellular Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for TCR-T Cellular Immunotherapy by Country/Region, 2019, 2023 & 2030
2.2 TCR-T Cellular Immunotherapy Segment by Type
2.2.1 Autologous
2.2.2 Allogeneic
2.3 TCR-T Cellular Immunotherapy Market Size by Type
2.3.1 TCR-T Cellular Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
2.4 TCR-T Cellular Immunotherapy Segment by Application
2.4.1 Cervical Cancer
2.4.2 Colorectal Cancer
2.4.3 Esophageal Cancer
2.4.4 Pancreatic Cancer
2.4.5 Lung Cancer
2.5 TCR-T Cellular Immunotherapy Market Size by Application
2.5.1 TCR-T Cellular Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
3 TCR-T CELLULAR IMMUNOTHERAPY MARKET SIZE BY PLAYER
3.1 TCR-T Cellular Immunotherapy Market Size Market Share by Player
3.1.1 Global TCR-T Cellular Immunotherapy Revenue by Player (2019-2024)
3.1.2 Global TCR-T Cellular Immunotherapy Revenue Market Share by Player (2019-2024)
3.2 Global TCR-T Cellular Immunotherapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 TCR-T CELLULAR IMMUNOTHERAPY BY REGION
4.1 TCR-T Cellular Immunotherapy Market Size by Region (2019-2024)
4.2 Global TCR-T Cellular Immunotherapy Annual Revenue by Country/Region (2019-2024)
4.3 Americas TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.4 APAC TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.5 Europe TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
4.6 Middle East & Africa TCR-T Cellular Immunotherapy Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas TCR-T Cellular Immunotherapy Market Size by Country (2019-2024)
5.2 Americas TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
5.3 Americas TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC TCR-T Cellular Immunotherapy Market Size by Region (2019-2024)
6.2 APAC TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
6.3 APAC TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe TCR-T Cellular Immunotherapy Market Size by Country (2019-2024)
7.2 Europe TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
7.3 Europe TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa TCR-T Cellular Immunotherapy by Region (2019-2024)
8.2 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Type (2019-2024)
8.3 Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL TCR-T CELLULAR IMMUNOTHERAPY MARKET FORECAST
10.1 Global TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.1.1 Global TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.1.2 Americas TCR-T Cellular Immunotherapy Forecast
10.1.3 APAC TCR-T Cellular Immunotherapy Forecast
10.1.4 Europe TCR-T Cellular Immunotherapy Forecast
10.1.5 Middle East & Africa TCR-T Cellular Immunotherapy Forecast
10.2 Americas TCR-T Cellular Immunotherapy Forecast by Country (2025-2030)
10.2.1 United States Market TCR-T Cellular Immunotherapy Forecast
10.2.2 Canada Market TCR-T Cellular Immunotherapy Forecast
10.2.3 Mexico Market TCR-T Cellular Immunotherapy Forecast
10.2.4 Brazil Market TCR-T Cellular Immunotherapy Forecast
10.3 APAC TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.3.1 China TCR-T Cellular Immunotherapy Market Forecast
10.3.2 Japan Market TCR-T Cellular Immunotherapy Forecast
10.3.3 Korea Market TCR-T Cellular Immunotherapy Forecast
10.3.4 Southeast Asia Market TCR-T Cellular Immunotherapy Forecast
10.3.5 India Market TCR-T Cellular Immunotherapy Forecast
10.3.6 Australia Market TCR-T Cellular Immunotherapy Forecast
10.4 Europe TCR-T Cellular Immunotherapy Forecast by Country (2025-2030)
10.4.1 Germany Market TCR-T Cellular Immunotherapy Forecast
10.4.2 France Market TCR-T Cellular Immunotherapy Forecast
10.4.3 UK Market TCR-T Cellular Immunotherapy Forecast
10.4.4 Italy Market TCR-T Cellular Immunotherapy Forecast
10.4.5 Russia Market TCR-T Cellular Immunotherapy Forecast
10.5 Middle East & Africa TCR-T Cellular Immunotherapy Forecast by Region (2025-2030)
10.5.1 Egypt Market TCR-T Cellular Immunotherapy Forecast
10.5.2 South Africa Market TCR-T Cellular Immunotherapy Forecast
10.5.3 Israel Market TCR-T Cellular Immunotherapy Forecast
10.5.4 Turkey Market TCR-T Cellular Immunotherapy Forecast
10.6 Global TCR-T Cellular Immunotherapy Forecast by Type (2025-2030)
10.7 Global TCR-T Cellular Immunotherapy Forecast by Application (2025-2030)
10.7.1 GCC Countries Market TCR-T Cellular Immunotherapy Forecast
11 KEY PLAYERS ANALYSIS
11.1 BioNTech
11.1.1 BioNTech Company Information
11.1.2 BioNTech TCR-T Cellular Immunotherapy Product Offered
11.1.3 BioNTech TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 BioNTech Main Business Overview
11.1.5 BioNTech Latest Developments
11.2 Adaptimmune
11.2.1 Adaptimmune Company Information
11.2.2 Adaptimmune TCR-T Cellular Immunotherapy Product Offered
11.2.3 Adaptimmune TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Adaptimmune Main Business Overview
11.2.5 Adaptimmune Latest Developments
11.3 Immunocore
11.3.1 Immunocore Company Information
11.3.2 Immunocore TCR-T Cellular Immunotherapy Product Offered
11.3.3 Immunocore TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Immunocore Main Business Overview
11.3.5 Immunocore Latest Developments
11.4 Medigene AG
11.4.1 Medigene AG Company Information
11.4.2 Medigene AG TCR-T Cellular Immunotherapy Product Offered
11.4.3 Medigene AG TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Medigene AG Main Business Overview
11.4.5 Medigene AG Latest Developments
11.5 bluebird bio
11.5.1 bluebird bio Company Information
11.5.2 bluebird bio TCR-T Cellular Immunotherapy Product Offered
11.5.3 bluebird bio TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 bluebird bio Main Business Overview
11.5.5 bluebird bio Latest Developments
11.6 TCR2 Therapeutics
11.6.1 TCR2 Therapeutics Company Information
11.6.2 TCR2 Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.6.3 TCR2 Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 TCR2 Therapeutics Main Business Overview
11.6.5 TCR2 Therapeutics Latest Developments
11.7 Immatics
11.7.1 Immatics Company Information
11.7.2 Immatics TCR-T Cellular Immunotherapy Product Offered
11.7.3 Immatics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Immatics Main Business Overview
11.7.5 Immatics Latest Developments
11.8 TScan Therapeutics
11.8.1 TScan Therapeutics Company Information
11.8.2 TScan Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.8.3 TScan Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 TScan Therapeutics Main Business Overview
11.8.5 TScan Therapeutics Latest Developments
11.9 3T Biosciences
11.9.1 3T Biosciences Company Information
11.9.2 3T Biosciences TCR-T Cellular Immunotherapy Product Offered
11.9.3 3T Biosciences TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 3T Biosciences Main Business Overview
11.9.5 3T Biosciences Latest Developments
11.10 Adaptive Biotechnologies
11.10.1 Adaptive Biotechnologies Company Information
11.10.2 Adaptive Biotechnologies TCR-T Cellular Immunotherapy Product Offered
11.10.3 Adaptive Biotechnologies TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Adaptive Biotechnologies Main Business Overview
11.10.5 Adaptive Biotechnologies Latest Developments
11.11 Kite Pharma
11.11.1 Kite Pharma Company Information
11.11.2 Kite Pharma TCR-T Cellular Immunotherapy Product Offered
11.11.3 Kite Pharma TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Kite Pharma Main Business Overview
11.11.5 Kite Pharma Latest Developments
11.12 RootPath
11.12.1 RootPath Company Information
11.12.2 RootPath TCR-T Cellular Immunotherapy Product Offered
11.12.3 RootPath TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 RootPath Main Business Overview
11.12.5 RootPath Latest Developments
11.13 Eureka Therapeutics
11.13.1 Eureka Therapeutics Company Information
11.13.2 Eureka Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.13.3 Eureka Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Eureka Therapeutics Main Business Overview
11.13.5 Eureka Therapeutics Latest Developments
11.14 Lion TCR
11.14.1 Lion TCR Company Information
11.14.2 Lion TCR TCR-T Cellular Immunotherapy Product Offered
11.14.3 Lion TCR TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Lion TCR Main Business Overview
11.14.5 Lion TCR Latest Developments
11.15 Guangzhou Xiangxue Pharmaceutical
11.15.1 Guangzhou Xiangxue Pharmaceutical Company Information
11.15.2 Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Product Offered
11.15.3 Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Guangzhou Xiangxue Pharmaceutical Main Business Overview
11.15.5 Guangzhou Xiangxue Pharmaceutical Latest Developments
11.16 Fosun Kite Biotechnology
11.16.1 Fosun Kite Biotechnology Company Information
11.16.2 Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.16.3 Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Fosun Kite Biotechnology Main Business Overview
11.16.5 Fosun Kite Biotechnology Latest Developments
11.17 Shanghai JW Therapeutics
11.17.1 Shanghai JW Therapeutics Company Information
11.17.2 Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Product Offered
11.17.3 Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Shanghai JW Therapeutics Main Business Overview
11.17.5 Shanghai JW Therapeutics Latest Developments
11.18 Shanghai Heng Rui Yuan Zheng Biotechnology
11.18.1 Shanghai Heng Rui Yuan Zheng Biotechnology Company Information
11.18.2 Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.18.3 Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Shanghai Heng Rui Yuan Zheng Biotechnology Main Business Overview
11.18.5 Shanghai Heng Rui Yuan Zheng Biotechnology Latest Developments
11.19 Shenzhen Innovation Immunotechnology
11.19.1 Shenzhen Innovation Immunotechnology Company Information
11.19.2 Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Product Offered
11.19.3 Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Shenzhen Innovation Immunotechnology Main Business Overview
11.19.5 Shenzhen Innovation Immunotechnology Latest Developments
11.20 Suzhou Neowise Biotechnology
11.20.1 Suzhou Neowise Biotechnology Company Information
11.20.2 Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.20.3 Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Suzhou Neowise Biotechnology Main Business Overview
11.20.5 Suzhou Neowise Biotechnology Latest Developments
11.21 Shenzhen BinDeBio Technology
11.21.1 Shenzhen BinDeBio Technology Company Information
11.21.2 Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Product Offered
11.21.3 Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Shenzhen BinDeBio Technology Main Business Overview
11.21.5 Shenzhen BinDeBio Technology Latest Developments
11.22 Beijing CorreGene Biotechnology
11.22.1 Beijing CorreGene Biotechnology Company Information
11.22.2 Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.22.3 Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Beijing CorreGene Biotechnology Main Business Overview
11.22.5 Beijing CorreGene Biotechnology Latest Developments
11.23 TCRCure Biopharma Technology
11.23.1 TCRCure Biopharma Technology Company Information
11.23.2 TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Product Offered
11.23.3 TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 TCRCure Biopharma Technology Main Business Overview
11.23.5 TCRCure Biopharma Technology Latest Developments
11.24 BriSTAR Immunotech
11.24.1 BriSTAR Immunotech Company Information
11.24.2 BriSTAR Immunotech TCR-T Cellular Immunotherapy Product Offered
11.24.3 BriSTAR Immunotech TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 BriSTAR Immunotech Main Business Overview
11.24.5 BriSTAR Immunotech Latest Developments
11.25 Shanghai iCell Biotechnology
11.25.1 Shanghai iCell Biotechnology Company Information
11.25.2 Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Product Offered
11.25.3 Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Revenue, Gross Margin and Market Share (2019-2024)
11.25.4 Shanghai iCell Biotechnology Main Business Overview
11.25.5 Shanghai iCell Biotechnology Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. TCR-T Cellular Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. TCR-T Cellular Immunotherapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Autologous
Table 4. Major Players of Allogeneic
Table 5. TCR-T Cellular Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 7. Global TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Table 8. TCR-T Cellular Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 10. Global TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Table 11. Global TCR-T Cellular Immunotherapy Revenue by Player (2019-2024) & ($ millions)
Table 12. Global TCR-T Cellular Immunotherapy Revenue Market Share by Player (2019-2024)
Table 13. TCR-T Cellular Immunotherapy Key Players Head office and Products Offered
Table 14. TCR-T Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 18. Global TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Table 19. Global TCR-T Cellular Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global TCR-T Cellular Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas TCR-T Cellular Immunotherapy Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Country (2019-2024)
Table 23. Americas TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Table 25. Americas TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Table 27. APAC TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Table 29. APAC TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe TCR-T Cellular Immunotherapy Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Country (2019-2024)
Table 33. Europe TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of TCR-T Cellular Immunotherapy
Table 39. Key Market Challenges & Risks of TCR-T Cellular Immunotherapy
Table 40. Key Industry Trends of TCR-T Cellular Immunotherapy
Table 41. Global TCR-T Cellular Immunotherapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global TCR-T Cellular Immunotherapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global TCR-T Cellular Immunotherapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. BioNTech Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 46. BioNTech TCR-T Cellular Immunotherapy Product Offered
Table 47. BioNTech TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. BioNTech Main Business
Table 49. BioNTech Latest Developments
Table 50. Adaptimmune Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 51. Adaptimmune TCR-T Cellular Immunotherapy Product Offered
Table 52. Adaptimmune TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Adaptimmune Main Business
Table 54. Adaptimmune Latest Developments
Table 55. Immunocore Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 56. Immunocore TCR-T Cellular Immunotherapy Product Offered
Table 57. Immunocore TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Immunocore Main Business
Table 59. Immunocore Latest Developments
Table 60. Medigene AG Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 61. Medigene AG TCR-T Cellular Immunotherapy Product Offered
Table 62. Medigene AG TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Medigene AG Main Business
Table 64. Medigene AG Latest Developments
Table 65. bluebird bio Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 66. bluebird bio TCR-T Cellular Immunotherapy Product Offered
Table 67. bluebird bio TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. bluebird bio Main Business
Table 69. bluebird bio Latest Developments
Table 70. TCR2 Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 71. TCR2 Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 72. TCR2 Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. TCR2 Therapeutics Main Business
Table 74. TCR2 Therapeutics Latest Developments
Table 75. Immatics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 76. Immatics TCR-T Cellular Immunotherapy Product Offered
Table 77. Immatics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Immatics Main Business
Table 79. Immatics Latest Developments
Table 80. TScan Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 81. TScan Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 82. TScan Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. TScan Therapeutics Main Business
Table 84. TScan Therapeutics Latest Developments
Table 85. 3T Biosciences Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 86. 3T Biosciences TCR-T Cellular Immunotherapy Product Offered
Table 87. 3T Biosciences TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. 3T Biosciences Main Business
Table 89. 3T Biosciences Latest Developments
Table 90. Adaptive Biotechnologies Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 91. Adaptive Biotechnologies TCR-T Cellular Immunotherapy Product Offered
Table 92. Adaptive Biotechnologies TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Adaptive Biotechnologies Main Business
Table 94. Adaptive Biotechnologies Latest Developments
Table 95. Kite Pharma Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 96. Kite Pharma TCR-T Cellular Immunotherapy Product Offered
Table 97. Kite Pharma TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Kite Pharma Main Business
Table 99. Kite Pharma Latest Developments
Table 100. RootPath Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 101. RootPath TCR-T Cellular Immunotherapy Product Offered
Table 102. RootPath TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. RootPath Main Business
Table 104. RootPath Latest Developments
Table 105. Eureka Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 106. Eureka Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 107. Eureka Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Eureka Therapeutics Main Business
Table 109. Eureka Therapeutics Latest Developments
Table 110. Lion TCR Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 111. Lion TCR TCR-T Cellular Immunotherapy Product Offered
Table 112. Lion TCR TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Lion TCR Main Business
Table 114. Lion TCR Latest Developments
Table 115. Guangzhou Xiangxue Pharmaceutical Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 116. Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Product Offered
Table 117. Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Guangzhou Xiangxue Pharmaceutical Main Business
Table 119. Guangzhou Xiangxue Pharmaceutical Latest Developments
Table 120. Fosun Kite Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 121. Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 122. Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Fosun Kite Biotechnology Main Business
Table 124. Fosun Kite Biotechnology Latest Developments
Table 125. Shanghai JW Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 126. Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 127. Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Shanghai JW Therapeutics Main Business
Table 129. Shanghai JW Therapeutics Latest Developments
Table 130. Shanghai Heng Rui Yuan Zheng Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 131. Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 132. Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Shanghai Heng Rui Yuan Zheng Biotechnology Main Business
Table 134. Shanghai Heng Rui Yuan Zheng Biotechnology Latest Developments
Table 135. Shenzhen Innovation Immunotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 136. Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Product Offered
Table 137. Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Shenzhen Innovation Immunotechnology Main Business
Table 139. Shenzhen Innovation Immunotechnology Latest Developments
Table 140. Suzhou Neowise Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 141. Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 142. Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Suzhou Neowise Biotechnology Main Business
Table 144. Suzhou Neowise Biotechnology Latest Developments
Table 145. Shenzhen BinDeBio Technology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 146. Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Product Offered
Table 147. Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Shenzhen BinDeBio Technology Main Business
Table 149. Shenzhen BinDeBio Technology Latest Developments
Table 150. Beijing CorreGene Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 151. Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 152. Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Beijing CorreGene Biotechnology Main Business
Table 154. Beijing CorreGene Biotechnology Latest Developments
Table 155. TCRCure Biopharma Technology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 156. TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Product Offered
Table 157. TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 158. TCRCure Biopharma Technology Main Business
Table 159. TCRCure Biopharma Technology Latest Developments
Table 160. BriSTAR Immunotech Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 161. BriSTAR Immunotech TCR-T Cellular Immunotherapy Product Offered
Table 162. BriSTAR Immunotech TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. BriSTAR Immunotech Main Business
Table 164. BriSTAR Immunotech Latest Developments
Table 165. Shanghai iCell Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 166. Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 167. Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 168. Shanghai iCell Biotechnology Main Business
Table 169. Shanghai iCell Biotechnology Latest Developments
Table 1. TCR-T Cellular Immunotherapy Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. TCR-T Cellular Immunotherapy Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Autologous
Table 4. Major Players of Allogeneic
Table 5. TCR-T Cellular Immunotherapy Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 7. Global TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Table 8. TCR-T Cellular Immunotherapy Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 10. Global TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Table 11. Global TCR-T Cellular Immunotherapy Revenue by Player (2019-2024) & ($ millions)
Table 12. Global TCR-T Cellular Immunotherapy Revenue Market Share by Player (2019-2024)
Table 13. TCR-T Cellular Immunotherapy Key Players Head office and Products Offered
Table 14. TCR-T Cellular Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 18. Global TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Table 19. Global TCR-T Cellular Immunotherapy Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global TCR-T Cellular Immunotherapy Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas TCR-T Cellular Immunotherapy Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Country (2019-2024)
Table 23. Americas TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 24. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Table 25. Americas TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Table 27. APAC TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Table 29. APAC TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 30. APAC TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe TCR-T Cellular Immunotherapy Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Country (2019-2024)
Table 33. Europe TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 34. Europe TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Type (2019-2024) & ($ millions)
Table 37. Middle East & Africa TCR-T Cellular Immunotherapy Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of TCR-T Cellular Immunotherapy
Table 39. Key Market Challenges & Risks of TCR-T Cellular Immunotherapy
Table 40. Key Industry Trends of TCR-T Cellular Immunotherapy
Table 41. Global TCR-T Cellular Immunotherapy Market Size Forecast by Region (2025-2030) & ($ millions)
Table 42. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Region (2025-2030)
Table 43. Global TCR-T Cellular Immunotherapy Market Size Forecast by Type (2025-2030) & ($ millions)
Table 44. Global TCR-T Cellular Immunotherapy Market Size Forecast by Application (2025-2030) & ($ millions)
Table 45. BioNTech Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 46. BioNTech TCR-T Cellular Immunotherapy Product Offered
Table 47. BioNTech TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. BioNTech Main Business
Table 49. BioNTech Latest Developments
Table 50. Adaptimmune Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 51. Adaptimmune TCR-T Cellular Immunotherapy Product Offered
Table 52. Adaptimmune TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Adaptimmune Main Business
Table 54. Adaptimmune Latest Developments
Table 55. Immunocore Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 56. Immunocore TCR-T Cellular Immunotherapy Product Offered
Table 57. Immunocore TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Immunocore Main Business
Table 59. Immunocore Latest Developments
Table 60. Medigene AG Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 61. Medigene AG TCR-T Cellular Immunotherapy Product Offered
Table 62. Medigene AG TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Medigene AG Main Business
Table 64. Medigene AG Latest Developments
Table 65. bluebird bio Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 66. bluebird bio TCR-T Cellular Immunotherapy Product Offered
Table 67. bluebird bio TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. bluebird bio Main Business
Table 69. bluebird bio Latest Developments
Table 70. TCR2 Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 71. TCR2 Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 72. TCR2 Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. TCR2 Therapeutics Main Business
Table 74. TCR2 Therapeutics Latest Developments
Table 75. Immatics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 76. Immatics TCR-T Cellular Immunotherapy Product Offered
Table 77. Immatics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Immatics Main Business
Table 79. Immatics Latest Developments
Table 80. TScan Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 81. TScan Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 82. TScan Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. TScan Therapeutics Main Business
Table 84. TScan Therapeutics Latest Developments
Table 85. 3T Biosciences Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 86. 3T Biosciences TCR-T Cellular Immunotherapy Product Offered
Table 87. 3T Biosciences TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. 3T Biosciences Main Business
Table 89. 3T Biosciences Latest Developments
Table 90. Adaptive Biotechnologies Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 91. Adaptive Biotechnologies TCR-T Cellular Immunotherapy Product Offered
Table 92. Adaptive Biotechnologies TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Adaptive Biotechnologies Main Business
Table 94. Adaptive Biotechnologies Latest Developments
Table 95. Kite Pharma Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 96. Kite Pharma TCR-T Cellular Immunotherapy Product Offered
Table 97. Kite Pharma TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Kite Pharma Main Business
Table 99. Kite Pharma Latest Developments
Table 100. RootPath Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 101. RootPath TCR-T Cellular Immunotherapy Product Offered
Table 102. RootPath TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. RootPath Main Business
Table 104. RootPath Latest Developments
Table 105. Eureka Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 106. Eureka Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 107. Eureka Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 108. Eureka Therapeutics Main Business
Table 109. Eureka Therapeutics Latest Developments
Table 110. Lion TCR Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 111. Lion TCR TCR-T Cellular Immunotherapy Product Offered
Table 112. Lion TCR TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Lion TCR Main Business
Table 114. Lion TCR Latest Developments
Table 115. Guangzhou Xiangxue Pharmaceutical Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 116. Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Product Offered
Table 117. Guangzhou Xiangxue Pharmaceutical TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Guangzhou Xiangxue Pharmaceutical Main Business
Table 119. Guangzhou Xiangxue Pharmaceutical Latest Developments
Table 120. Fosun Kite Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 121. Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 122. Fosun Kite Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Fosun Kite Biotechnology Main Business
Table 124. Fosun Kite Biotechnology Latest Developments
Table 125. Shanghai JW Therapeutics Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 126. Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Product Offered
Table 127. Shanghai JW Therapeutics TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Shanghai JW Therapeutics Main Business
Table 129. Shanghai JW Therapeutics Latest Developments
Table 130. Shanghai Heng Rui Yuan Zheng Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 131. Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 132. Shanghai Heng Rui Yuan Zheng Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Shanghai Heng Rui Yuan Zheng Biotechnology Main Business
Table 134. Shanghai Heng Rui Yuan Zheng Biotechnology Latest Developments
Table 135. Shenzhen Innovation Immunotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 136. Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Product Offered
Table 137. Shenzhen Innovation Immunotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Shenzhen Innovation Immunotechnology Main Business
Table 139. Shenzhen Innovation Immunotechnology Latest Developments
Table 140. Suzhou Neowise Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 141. Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 142. Suzhou Neowise Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Suzhou Neowise Biotechnology Main Business
Table 144. Suzhou Neowise Biotechnology Latest Developments
Table 145. Shenzhen BinDeBio Technology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 146. Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Product Offered
Table 147. Shenzhen BinDeBio Technology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Shenzhen BinDeBio Technology Main Business
Table 149. Shenzhen BinDeBio Technology Latest Developments
Table 150. Beijing CorreGene Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 151. Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 152. Beijing CorreGene Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Beijing CorreGene Biotechnology Main Business
Table 154. Beijing CorreGene Biotechnology Latest Developments
Table 155. TCRCure Biopharma Technology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 156. TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Product Offered
Table 157. TCRCure Biopharma Technology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 158. TCRCure Biopharma Technology Main Business
Table 159. TCRCure Biopharma Technology Latest Developments
Table 160. BriSTAR Immunotech Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 161. BriSTAR Immunotech TCR-T Cellular Immunotherapy Product Offered
Table 162. BriSTAR Immunotech TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. BriSTAR Immunotech Main Business
Table 164. BriSTAR Immunotech Latest Developments
Table 165. Shanghai iCell Biotechnology Details, Company Type, TCR-T Cellular Immunotherapy Area Served and Its Competitors
Table 166. Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Product Offered
Table 167. Shanghai iCell Biotechnology TCR-T Cellular Immunotherapy Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 168. Shanghai iCell Biotechnology Main Business
Table 169. Shanghai iCell Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. TCR-T Cellular Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global TCR-T Cellular Immunotherapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. TCR-T Cellular Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. TCR-T Cellular Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. TCR-T Cellular Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global TCR-T Cellular Immunotherapy Market Size Market Share by Type in 2023
Figure 10. TCR-T Cellular Immunotherapy in Cervical Cancer
Figure 11. Global TCR-T Cellular Immunotherapy Market: Cervical Cancer (2019-2024) & ($ millions)
Figure 12. TCR-T Cellular Immunotherapy in Colorectal Cancer
Figure 13. Global TCR-T Cellular Immunotherapy Market: Colorectal Cancer (2019-2024) & ($ millions)
Figure 14. TCR-T Cellular Immunotherapy in Esophageal Cancer
Figure 15. Global TCR-T Cellular Immunotherapy Market: Esophageal Cancer (2019-2024) & ($ millions)
Figure 16. TCR-T Cellular Immunotherapy in Pancreatic Cancer
Figure 17. Global TCR-T Cellular Immunotherapy Market: Pancreatic Cancer (2019-2024) & ($ millions)
Figure 18. TCR-T Cellular Immunotherapy in Lung Cancer
Figure 19. Global TCR-T Cellular Immunotherapy Market: Lung Cancer (2019-2024) & ($ millions)
Figure 20. Global TCR-T Cellular Immunotherapy Market Size Market Share by Application in 2023
Figure 21. Global TCR-T Cellular Immunotherapy Revenue Market Share by Player in 2023
Figure 22. Global TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 23. Americas TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 24. APAC TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 25. Europe TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 27. Americas TCR-T Cellular Immunotherapy Value Market Share by Country in 2023
Figure 28. United States TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Region in 2023
Figure 33. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 34. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 35. China TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 39. India TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Country in 2023
Figure 42. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 43. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 44. Germany TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 45. France TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 46. UK TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 52. Egypt TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 58. APAC TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 59. Europe TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 61. United States TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 62. Canada TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 63. Mexico TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 64. Brazil TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 65. China TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 66. Japan TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 67. Korea TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 69. India TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 70. Australia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 71. Germany TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 72. France TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 73. UK TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 74. Italy TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 75. Russia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 76. Egypt TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 77. South Africa TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 78. Israel TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 79. Turkey TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 81. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
Figure 1. TCR-T Cellular Immunotherapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global TCR-T Cellular Immunotherapy Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. TCR-T Cellular Immunotherapy Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. TCR-T Cellular Immunotherapy Sales Market Share by Country/Region (2023)
Figure 8. TCR-T Cellular Immunotherapy Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global TCR-T Cellular Immunotherapy Market Size Market Share by Type in 2023
Figure 10. TCR-T Cellular Immunotherapy in Cervical Cancer
Figure 11. Global TCR-T Cellular Immunotherapy Market: Cervical Cancer (2019-2024) & ($ millions)
Figure 12. TCR-T Cellular Immunotherapy in Colorectal Cancer
Figure 13. Global TCR-T Cellular Immunotherapy Market: Colorectal Cancer (2019-2024) & ($ millions)
Figure 14. TCR-T Cellular Immunotherapy in Esophageal Cancer
Figure 15. Global TCR-T Cellular Immunotherapy Market: Esophageal Cancer (2019-2024) & ($ millions)
Figure 16. TCR-T Cellular Immunotherapy in Pancreatic Cancer
Figure 17. Global TCR-T Cellular Immunotherapy Market: Pancreatic Cancer (2019-2024) & ($ millions)
Figure 18. TCR-T Cellular Immunotherapy in Lung Cancer
Figure 19. Global TCR-T Cellular Immunotherapy Market: Lung Cancer (2019-2024) & ($ millions)
Figure 20. Global TCR-T Cellular Immunotherapy Market Size Market Share by Application in 2023
Figure 21. Global TCR-T Cellular Immunotherapy Revenue Market Share by Player in 2023
Figure 22. Global TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 23. Americas TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 24. APAC TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 25. Europe TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 26. Middle East & Africa TCR-T Cellular Immunotherapy Market Size 2019-2024 ($ millions)
Figure 27. Americas TCR-T Cellular Immunotherapy Value Market Share by Country in 2023
Figure 28. United States TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 29. Canada TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 30. Mexico TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 31. Brazil TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 32. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Region in 2023
Figure 33. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 34. APAC TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 35. China TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 36. Japan TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 37. South Korea TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 38. Southeast Asia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 39. India TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 40. Australia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 41. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Country in 2023
Figure 42. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 43. Europe TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 44. Germany TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 45. France TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 46. UK TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 47. Italy TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 48. Russia TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 49. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Region (2019-2024)
Figure 50. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Type (2019-2024)
Figure 51. Middle East & Africa TCR-T Cellular Immunotherapy Market Size Market Share by Application (2019-2024)
Figure 52. Egypt TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 53. South Africa TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 54. Israel TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 55. Turkey TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 56. GCC Countries TCR-T Cellular Immunotherapy Market Size Growth 2019-2024 ($ millions)
Figure 57. Americas TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 58. APAC TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 59. Europe TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 60. Middle East & Africa TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 61. United States TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 62. Canada TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 63. Mexico TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 64. Brazil TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 65. China TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 66. Japan TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 67. Korea TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 68. Southeast Asia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 69. India TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 70. Australia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 71. Germany TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 72. France TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 73. UK TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 74. Italy TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 75. Russia TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 76. Egypt TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 77. South Africa TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 78. Israel TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 79. Turkey TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 80. GCC Countries TCR-T Cellular Immunotherapy Market Size 2025-2030 ($ millions)
Figure 81. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Type (2025-2030)
Figure 82. Global TCR-T Cellular Immunotherapy Market Size Market Share Forecast by Application (2025-2030)
